Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Anti-PD-L1/Anti-VEGF-A Bispecific Antibody BNT327

Review the clinical trials studying anti-pd-l1/anti-vegf-a bispecific antibody bnt327 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-8 of 8

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
Status: Active
Location: 14 locations
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
Status: Active
Location: 7 locations
Safety, Effectiveness, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Status: Active
Location: 3 locations
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy Following Chemoimmunotherapy
Status: Active
Location: 2 locations
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Status: Active
Location: 2 locations
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Status: Active
Location: Hackensack University Medical Center, Hackensack, New Jersey
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas